Very happy to see our #UNLOADECMO trial started in 12/22 with 4 patients already included. #MCS therapy in cardiogenic shock still very challenging. #ECLS-SHOCK (#ECMO)and #DanGer-Shock (#Impella) running already and will be finished soon.
🧵5/6 We will randomize patients with CS in need of ECMO to LV unloading with an #Impella on top of #ECMO vs. control (IABP unloading as bail out). #ECPELLA vs #ECMO
🧵6/6 Next centers (up to 10 in 🇩🇪) will be initiated in 01/23. This will be a challenging endeavor to see whether #ECPELLA will be a winner in #CS. Will be presented by @BenediktSchrage in a couple of years ... clinicaltrials.gov/ct2/show/NCT05…